Beta-Amyloid & Cell Death Mechanisms in Skeletal Muscle
β-淀粉样蛋白
基本信息
- 批准号:6849286
- 负责人:
- 金额:$ 27.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-03-15 至 2007-02-28
- 项目状态:已结题
- 来源:
- 关键词:Alphaherpesvirinaeamyloid proteinsapoptosiscell proliferationcellular pathologycytotoxicityelectron microscopyenzyme activityenzyme linked immunosorbent assaygenetically modified animalshuman tissueimmunofluorescence techniqueimmunoprecipitationinclusion bodylaboratory mousemitochondriamyositismyotubespolymerase chain reactionproteasomeprotein kinasestriated musclesterminal nick end labelingtissue /cell culturetransfection /expression vectorwestern blottings
项目摘要
DESCRIPTION (Adapted from applicant's abstract): Inclusion Body Myositis (IBM)
is the most common muscle disorder in patients over 50 years of age. IBM shares
several features with another age-related degenerative disorder, Alzheimer's
disease (AD): 1) there are both sporadic and autosomal inherited forms, 2)
local inflammatory collections are characteristic but immunosuppressive
therapies are only marginally effective, and 3) accumulations of AD-related
proteins are a histopathological hallmark. Congo red- reactive deposits
consisting of the beta-amyloid peptide (Abeta) are the most notable feature. In
contrast with the extra-cellular amyloid plaques of AD, the amyloid deposits of
IBM are intracellular. Several other proteins accumulate intracellularly in the
vacuolated myofibers of IBM including other epitopes of beta-amyloid precursor
protein, hyperphosphorylated filaments comprised of the microtubule-associated
protein tau, ubiquitin, the cellular prion protein, and cyclin dependent kinase
5 (cdk5).
The mechanism of muscle cell loss in IBM remains a mystery. Abeta is known to
induce programmed cell death (apoptosis) of neurons in culture and in some
transgenic mouse models for Alzheimer's disease. In Aim 1, the applicants
hypothesize that intracellular accumulation of Abeta in cultured skeletal
muscle myotubes will induce apoptosis. Abeta deposition is provoked using an
inducible promoter, a heterologous viral gene transfer system, or by direct
injection. They will examine the role of the proteasome and the parkin gene in
the genesis of protein accumulations. In Aim 2, Abeta is established as a
myotoxins by a thorough examination of human IBM biopsy specimens, for a
correlation between Abeta accumulation and several markers of apoptosis. Mouse
muscle is similarly analyzed after direct injection of an Abeta-encoding
adenoviral gene construct. Their 2nd hypothesis is that deposition of
intracellular Abeta adversely affects Akt kinase-dependent muscle cell survival
pathways and in Aim 3 we will determine if Abeta inhibits Akt activity.
Furthermore, the applicants will seek evidence that Abeta induces deleterious
attempts by cells to re-enter the developmental or even the cell cycle, related
to Akt, p21 Cip1/Wafl or cyclin D dysfunction. Evidence for tau
hyperphosphorylation from unhindered GSK-3beta activity will be sought. In Aim
4 the functional significance of Akt inhibition by Abeta is examined by asking
whether Akt activation will protect muscle cells forced to overexpress Abeta
from cell death. While some of the findings may be relevant to neuronal
systems, they will provide insight into a novel mechanism of Abeta injury and
the complex regulation of cell survival, replication and apoptosis from a key
survival signal control point.
描述(改编自申请人摘要):包涵体肌炎(IBM)
是50岁以上患者中最常见的肌肉疾病。IBM股价
另一种与年龄相关的退行性疾病阿尔茨海默氏症的几个特征
疾病(AD):1)有散发和常染色体遗传形式,2)
局部炎性聚集是特征性的,但免疫抑制
治疗只是轻微有效,和3)AD相关的累积
蛋白质是组织病理学的标志。刚果红活性矿床
由β-淀粉样肽(Abeta)组成的蛋白质是最显著的特征。在
与AD的细胞外淀粉样斑块相比,
IBM是细胞内的。其他几种蛋白质在细胞内积累,
包括β-淀粉样蛋白前体的其他表位的IBM空泡化肌纤维
蛋白质,过度磷酸化的细丝组成的微管相关的
tau蛋白、泛素、细胞朊病毒蛋白和细胞周期蛋白依赖性激酶
5(cdk5)。
IBM肌肉细胞丢失的机制仍然是一个谜。众所周知,Abeta
诱导培养物中神经元程序性细胞死亡(凋亡),
阿尔茨海默病的转基因小鼠模型。在目标1中,申请人
假设在培养骨骼肌细胞内A β积聚
肌肉肌管将诱导细胞凋亡。Abeta沉积是由
诱导型启动子、异源病毒基因转移系统,或通过直接
注射他们将研究蛋白酶体和parkin基因在
蛋白质积累的起源。在目标2中,Abeta被确定为
通过对人IBM活检标本进行彻底检查,
Abeta积累与几种凋亡标志物之间的相关性。鼠标
在直接注射编码A β的
腺病毒基因构建体。他们的第二个假设是,
细胞内Abeta不利地影响Akt激酶依赖性肌细胞存活
在Aim 3中,我们将确定Abeta是否抑制Akt活性。
此外,申请人将寻求证据,证明Abeta引起有害的
细胞试图重新进入发育甚至细胞周期,
Akt、p21 Cip 1/Wafl或cyclin D功能障碍。tau的证据
将寻求来自不受阻碍的GSK-3 β活性的过度磷酸化。在Aim中
4通过询问来检验Abeta抑制Akt的功能意义。
Akt激活是否会保护被迫过度表达Abeta的肌肉细胞
细胞死亡。虽然有些发现可能与神经元
系统,他们将提供深入了解Abeta损伤的新机制,
细胞存活、复制和凋亡的复杂调控从一个关键
生存信号控制点
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function.
Parkin 可逆转细胞内 β-淀粉样蛋白的积累及其对蛋白酶体功能的负面影响。
- DOI:10.1002/jnr.22178
- 发表时间:2010-01
- 期刊:
- 影响因子:4.2
- 作者:Rosen, Kenneth M.;Moussa, Charbel E. -H.;Lee, Han-Kyu;Kumar, Pravir;Kitada, Tohru;Qin, Gangjian;Fu, Qinghao;Querfurth, Henry W.
- 通讯作者:Querfurth, Henry W.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HENRY W QUERFURTH其他文献
HENRY W QUERFURTH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HENRY W QUERFURTH', 18)}}的其他基金
A Novel Insulin Pathway Agonist for Alzheimer's Disease
一种治疗阿尔茨海默病的新型胰岛素途径激动剂
- 批准号:
8520608 - 财政年份:2013
- 资助金额:
$ 27.68万 - 项目类别:
Beta-Amyloid & Cell Death Mechanisms in Skeletal Muscle
β-淀粉样蛋白
- 批准号:
6472401 - 财政年份:2002
- 资助金额:
$ 27.68万 - 项目类别:
Beta-Amyloid & Cell Death Mechanisms in Skeletal Muscle
β-淀粉样蛋白
- 批准号:
6711076 - 财政年份:2002
- 资助金额:
$ 27.68万 - 项目类别:
Beta-Amyloid & Cell Death Mechanisms in Skeletal Muscle
β-淀粉样蛋白
- 批准号:
6624108 - 财政年份:2002
- 资助金额:
$ 27.68万 - 项目类别:
AMYLOID PRECURSOR PROTEIN IN BIOLOGY & PATHOGENESIS OF A
生物学中的淀粉样前体蛋白
- 批准号:
3084841 - 财政年份:1993
- 资助金额:
$ 27.68万 - 项目类别:
相似海外基金
Development of aggregation inhibition strategy for pathogenic amyloid proteins
致病性淀粉样蛋白聚集抑制策略的开发
- 批准号:
16H06216 - 财政年份:2016
- 资助金额:
$ 27.68万 - 项目类别:
Grant-in-Aid for Young Scientists (A)
Elucidation of the mechanisms on aggregation and toxicity of plant amyloid proteins which are toxic in the presence of metals
阐明在金属存在下有毒的植物淀粉样蛋白的聚集和毒性机制
- 批准号:
23380192 - 财政年份:2011
- 资助金额:
$ 27.68万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Demonstration of the abnormal conformational transition of amyloid proteins and it's application as an early diagnostic tool
淀粉样蛋白异常构象转变的演示及其作为早期诊断工具的应用
- 批准号:
21200072 - 财政年份:2009
- 资助金额:
$ 27.68万 - 项目类别:
Grant-in-Aid for Scientific Research on Innovative Areas (Research a proposed research project)
Metabolism of amyloid proteins and methods for detecting amyloid proteins
淀粉样蛋白的代谢和检测淀粉样蛋白的方法
- 批准号:
21790541 - 财政年份:2009
- 资助金额:
$ 27.68万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of aggregation disrupters for amyloid proteins
淀粉样蛋白聚集破坏剂的开发
- 批准号:
17310132 - 财政年份:2005
- 资助金额:
$ 27.68万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Inhibition of axonal transport of hippocampal neurons by amyloid proteins: relation to Alzheimer's disease
淀粉样蛋白抑制海马神经元轴突运输:与阿尔茨海默病的关系
- 批准号:
11670638 - 财政年份:1999
- 资助金额:
$ 27.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
RAB GTPASES AND TRAFFICKING OF BETA AMYLOID PROTEINS
RAB GTP 酶和 β 淀粉样蛋白的贩运
- 批准号:
6149928 - 财政年份:1998
- 资助金额:
$ 27.68万 - 项目类别: